RET gene fusions or rearrangements represent a major aberration in NSCLC, accounting for 1–2% of cases, with the most common fusion variants involving KIF5B-RET and CCDC6-RET [6]. The gene discussed is KIF5B; the disease is non-small cell lung carcinoma.